Medtronic and Cornerstone Robotics Expand Robotic Surgery
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
Silver Spring, Maryland, August 19, 2026 The U.S. Food and Drug Administration (FDA) has authorized Aletta, a first-of-its-kind standalone...
BROOKLYN PARK, Minn., June 11, 2026 Airiver Medical has announced the successful treatment of the first patient in its...
SAN FRANCISCO, June 10, 2026 Matter Bio has announced that the U.S. Food and Drug Administration (FDA) has cleared...
TORONTO, June 9, 2026 SpinaFX Medical has achieved a major regulatory milestone after receiving U.S. Food and Drug Administration...
YOKNEAM, Israel – May 8, 2026 Lumenis announced that its groundbreaking hair restoration platform FoLix™ has received the Hair...
PALO ALTO, California, May 1, 2026 Sonire Therapeutics Inc. announced the initiation of its first U.S. clinical trial, SUNRISE-II,...
Amsterdam, Netherlands – April 23, 2026 Philips announced the launch of its next-generation Bridge Plus Occlusion Balloon, a life-saving...
AUSTIN, TEXAS, USA, April 14, 2026 TOBY, Inc. has received FDA Breakthrough Device Designation for its urine-based Multi-Cancer Early...
